# Dirghayu (‡§¶‡•Ä‡§∞‡•ç‡§ò‡§æ‡§Ø‡•Å) üß¨

> India-First Longevity-Focused Whole Genome Mapping with Protein-Based Vulnerability Prediction

**Dirghayu** (Sanskrit: "long life") is an open platform for whole genome sequencing analysis focused on longevity and healthspan optimization for Indian populations.

## Vision

Build a comprehensive genomics platform that:
- Maps genetic variations across diverse Indian populations
- Predicts protein-level vulnerabilities using structural biology
- Identifies longevity-associated genetic patterns
- Provides clinically actionable insights calibrated for Indian genetics

## Architecture Overview

```
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ                     Data Acquisition Layer                   ‚îÇ
‚îÇ  ‚Ä¢ WGS Data (FASTQ) ‚Ä¢ Clinical Phenotypes ‚Ä¢ Medical Records ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
                      ‚îÇ
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñº‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ                  Variant Calling Pipeline                     ‚îÇ
‚îÇ  BWA-MEM2 ‚Üí DeepVariant/GATK ‚Üí VEP Annotation ‚Üí QC          ‚îÇ
‚îÇ  Reference: GRCh38 + Indian-specific variant frequencies     ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
                      ‚îÇ
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñº‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ                 Protein Structure Analysis                    ‚îÇ
‚îÇ  ‚Ä¢ AlphaFold2/ESMFold structures                             ‚îÇ
‚îÇ  ‚Ä¢ Variant ‚Üí Protein stability (FoldX, Rosetta)              ‚îÇ
‚îÇ  ‚Ä¢ Pathway impact analysis (mTOR, insulin/IGF-1, autophagy)  ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
                      ‚îÇ
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñº‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ              Risk Prediction & ML Models                      ‚îÇ
‚îÇ  ‚Ä¢ Polygenic Risk Scores (PRS) for Indian populations        ‚îÇ
‚îÇ  ‚Ä¢ Protein pathogenicity: AlphaMissense, EVE                 ‚îÇ
‚îÇ  ‚Ä¢ Longevity biomarkers & healthspan prediction              ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚î¨‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
                      ‚îÇ
‚îå‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚ñº‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îê
‚îÇ                  Clinical Decision Support                    ‚îÇ
‚îÇ  ‚Ä¢ Personalized intervention recommendations                 ‚îÇ
‚îÇ  ‚Ä¢ Integration with Indian healthcare (ABDM, Ayushman)       ‚îÇ
‚îÇ  ‚Ä¢ ICMR/regulatory compliance                                ‚îÇ
‚îî‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îÄ‚îò
```

## Key Components

### 1. Data Layer

**Sequencing Pipeline**
```bash
# Quality control & alignment
fastp ‚Üí BWA-MEM2 (GRCh38) ‚Üí sambamba sort/markdup

# Variant calling
DeepVariant / GATK HaplotypeCaller

# Annotation
VEP (Ensembl) + custom Indian variant frequencies
```

**Reference Data**
- **Base Reference**: GRCh38 (hg38)
- **Indian Population Data**: 
  - GenomeIndia (1000+ genomes)
  - IndiGen (1000+ diverse Indian genomes)
  - IGVDB (Indian Genetic Variation Database)
- **Longevity Reference Sets**:
  - CentenARian cohorts
  - Healthy aging genomics datasets

**Storage Architecture**
- Raw FASTQ: S3/Object storage (compressed)
- Aligned BAM/CRAM: ~30-50GB per genome
- Variants: Parquet/Delta Lake (~100MB per genome)
- Protein structures: HDF5/Zarr format
- Phenotype data: PostgreSQL + TimescaleDB

### 2. Protein Vulnerability Prediction System

**Structural Analysis Pipeline**

```python
# Pseudocode workflow
variant = get_coding_variant(vcf_record)
protein = map_to_protein(variant)

# Get protein structure
if protein in alphafold_db:
    structure = fetch_alphafold(protein)
else:
    structure = predict_structure(protein.sequence)

# Predict variant impact
wild_type_stability = calculate_folding_energy(structure)
mutant_structure = apply_mutation(structure, variant)
mutant_stability = calculate_folding_energy(mutant_structure)

delta_delta_g = mutant_stability - wild_type_stability
pathogenicity_score = predict_pathogenicity(delta_delta_g, conservation)
```

**Tools & Methods**
- **Structure Prediction**: AlphaFold2, ESMFold, RoseTTAFold
- **Stability Analysis**: FoldX, Rosetta, CUPSAT
- **Pathogenicity Prediction**: AlphaMissense, EVE, REVEL
- **Aggregation Propensity**: TANGO, Aggrescan3D

**Target Protein Families**
- DNA repair enzymes (BRCA1/2, TP53, etc.)
- Metabolic regulators (mTOR pathway, AMPK)
- Proteostasis machinery (HSPs, proteasome subunits)
- Mitochondrial proteins (respiratory chain complexes)
- Autophagy components (ATG genes)

### 3. Longevity-Associated Pathways

**Key Biological Pathways**

1. **Insulin/IGF-1 Signaling**
   - Genes: IGF1R, IRS1, FOXO3A
   - Variants associated with centenarian status

2. **mTOR Pathway**
   - Genes: MTOR, RPTOR, RICTOR
   - Nutrient sensing & cellular growth

3. **Sirtuins & NAD+ Metabolism**
   - Genes: SIRT1-7, NAMPT, NMNAT1
   - Caloric restriction mimetics

4. **Autophagy & Proteostasis**
   - Genes: ATG5, ATG7, BECN1, ULK1
   - Cellular quality control

5. **Mitochondrial Function**
   - mtDNA variants
   - Nuclear-encoded mitochondrial genes
   - Oxidative phosphorylation complexes

6. **DNA Repair & Genome Maintenance**
   - Genes: WRN, BLM, RECQL4 (RecQ helicases)
   - Base excision repair (BER) pathway

### 4. ML & Risk Modeling

**Polygenic Risk Scores (PRS)**

```python
# Indian-population calibrated PRS
PRS_india = Œ£(Œ≤_i √ó SNP_i √ó ancestry_weight)

# Where:
# Œ≤_i = effect size calibrated for Indian populations
# SNP_i = genotype at locus i
# ancestry_weight = adjustment for Indian subpopulation
```

**Disease Risk Models**
- Cardiovascular disease (CAD)
- Type 2 Diabetes (T2D) 
- Common cancers (breast, colorectal, lung)
- Alzheimer's disease
- Age-related macular degeneration

**Healthspan Prediction**
```
Healthspan Score = f(
    genetic_longevity_score,
    protein_vulnerability_burden,
    protective_variants,
    population_specific_modifiers
)
```

### 5. Clinical Integration

**Indian Healthcare System Integration**
- **ABDM (Ayushman Bharat Digital Mission)**: Health ID linking
- **EHR Standards**: FHIR-compliant genomic resources
- **Ayushman Bharat PM-JAY**: Insurance coverage pathways
- **ICMR Guidelines**: Ethical & regulatory compliance

**Actionable Insights**
- Personalized drug response (pharmacogenomics)
- Lifestyle intervention recommendations
- Preventive screening schedules
- Family cascade testing protocols

## Target Population Scale

### Phase 1: Pilot (2026-2027)
- **Sample Size**: 1,000 genomes
- **Coverage**: Major Indian ethnic groups
  - Indo-Aryan (North India)
  - Dravidian (South India)
  - Tibeto-Burman (Northeast India)
  - Austroasiatic (Central/Eastern India)
- **Phenotype Focus**: Healthy individuals 50+ years

### Phase 2: Expansion (2027-2029)
- **Sample Size**: 10,000 genomes
- **Centenarian Cohort**: 500+ individuals aged 90+
- **Disease Cohorts**: 2,000+ with age-related diseases
- **Rural Coverage**: 30% rural participants

### Phase 3: National Scale (2029+)
- **Sample Size**: 100,000+ genomes
- **Geographic Coverage**: All 28 states + 8 UTs
- **Integration**: National health registries

## Technology Stack

### Computational Infrastructure

**Bioinformatics Pipeline**
- **Languages**: Python, Rust, R
- **Workflow**: Nextflow, Snakemake
- **Compute**: AWS Batch, Google Life Sciences API
- **Containers**: Docker, Singularity

**Data Processing**
- **Variant Calling**: GATK, DeepVariant
- **Alignment**: BWA-MEM2, minimap2
- **QC**: FastQC, MultiQC, Picard
- **Annotation**: VEP, SnpEff, ANNOVAR

**ML & Analytics**
- **Frameworks**: PyTorch, TensorFlow, JAX
- **Structure Prediction**: AlphaFold2, ColabFold
- **Protein Modeling**: PyRosetta, OpenMM
- **ML Ops**: MLflow, Weights & Biases

**Storage & Databases**
- **Object Storage**: S3, Google Cloud Storage
- **Structured Data**: PostgreSQL, TimescaleDB
- **Variant DB**: Elasticsearch, Apache Druid
- **Graph DB**: Neo4j (protein interactions)

**Web Platform**
- **Backend**: FastAPI, GraphQL
- **Frontend**: React, Next.js
- **Visualization**: Plotly, IGV.js, Mol*

### Cost Optimization

**Per Genome Estimates (2026)**
- Sequencing (30x WGS): $200-300
- Compute (variant calling): $5-10
- Storage (5 years): $10-15
- Analysis (protein + ML): $20-30
- **Total**: ~$250-350 per genome

**Infrastructure Strategy**
- Spot/Preemptible instances for batch jobs
- Tiered storage (hot/warm/cold)
- Regional compute (AWS Mumbai, GCP Pune)
- Open-source tools over proprietary

## Research Questions

1. **Population Genetics**
   - What genetic variants are unique to Indian centenarians?
   - How do longevity variants differ across Indian ethnic groups?

2. **Protein Vulnerabilities**
   - Which protein-coding variants increase age-related disease risk?
   - Can we predict protein aggregation propensity from genome data?

3. **Gene-Environment Interactions**
   - How do genetic variants interact with Indian dietary patterns?
   - What is the role of consanguinity in rare disease burden?

4. **Therapeutic Targets**
   - Which druggable targets emerge from longevity genomics?
   - Can we repurpose existing drugs based on genetic insights?

## Ethical & Regulatory Framework

### Data Privacy
- GDPR-like protections
- Encryption at rest and in transit
- Federated learning where possible
- Patient consent management

### Regulatory Compliance
- **ICMR Guidelines**: Biomedical research ethics
- **DBT Guidelines**: Genomic data sharing
- **CDSCO**: Drug development pathways
- **Genetic Counseling**: ACMG/AMP standards

### Community Engagement
- Return of results framework
- Tribal/indigenous consent protocols
- Public education campaigns
- Open science principles

## Collaboration Opportunities

### Academic Partners
- CSIR-IGIB (Institute of Genomics & Integrative Biology)
- THSTI (Translational Health Science & Technology Institute)
- IISc, IITs (Computational biology groups)
- NIMHANS (Aging research)

### Clinical Partners
- AIIMS (All India Institute of Medical Sciences)
- PGIMER Chandigarh
- CMC Vellore
- Tata Memorial Hospital

### Industry Partners
- Genomics companies (MedGenome, 4baseCare)
- Pharma (Dr. Reddy's, Sun Pharma)
- Tech (TCS, Infosys healthcare divisions)
- Cloud providers (AWS, Google, Microsoft)

## Roadmap

### Q1-Q2 2026: Foundation
- [ ] Infrastructure setup (compute, storage, workflows)
- [ ] Reference database curation (Indian variants)
- [ ] Pilot cohort recruitment (n=100)
- [ ] Pipeline validation

### Q3-Q4 2026: Pilot Phase
- [ ] Process 1,000 genomes
- [ ] Protein structure prediction pipeline
- [ ] Initial PRS calibration
- [ ] Web platform MVP

### 2027: Scale & Validation
- [ ] Expand to 10,000 genomes
- [ ] Clinical validation studies
- [ ] ML model refinement
- [ ] Regulatory approvals

### 2028+: National Deployment
- [ ] 100,000+ genomes
- [ ] Integration with national health systems
- [ ] Commercial partnerships
- [ ] Open data release

## Contributing

We welcome contributions from:
- Bioinformaticians & computational biologists
- Structural biologists
- Machine learning researchers
- Clinical geneticists
- Software engineers
- Data scientists

See [CONTRIBUTING.md](CONTRIBUTING.md) for guidelines.

## License

TBD - likely dual license:
- Open source (Apache 2.0) for research use
- Commercial license for clinical applications

## Contact

**Project Lead**: [TBD]

**Institutions**: [TBD]

**Email**: dirghayu@[domain].in

---

> "‡§¶‡•Ä‡§∞‡•ç‡§ò‡§æ‡§Ø‡•Å‡§É ‡§Ö‡§∏‡•ç‡§§‡•Å" - May you live long

*Building the future of personalized longevity medicine for India*
